Back to Search
BLASE HENNESSY, M.D.
M.D.
Internal Medicine Physician
NPI: 1386936755IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
35122032(OH)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
TOLEDO MEDICAL COLLEGE
Class of 2011
Research & Publications (20)
Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer.
PMID 19435893·Cancer Res·2009
8-other
Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes.
PMID 19047281·J Clin Oncol·2009
8-other
Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression.
PMID 19491266·Cancer Res·2009
7-preclinical
Rak functions as a tumor suppressor by regulating PTEN protein stability and function.
PMID 19345329·Cancer Cell·2009
7-preclinical
Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
PMID 19440550·PLoS One·2009
8-other
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.
PMID 19573809·Cancer Cell·2009
8-other
The biology of ovarian cancer: new opportunities for translation.
PMID 19461667·Nat Rev Cancer·2009
6-review
Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach.
PMID 19318683·Blood·2009
8-other
Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumors.
PMID 19451593·Clin Cancer Res·2009
7-preclinical
Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.
PMID 19276248·Clin Cancer Res·2009
8-other
Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
PMID 19197997·Cancer·2009
8-other
A systems approach to analysis of molecular complexity in breast cancer.
PMID 19147744·Clin Cancer Res·2009
8-other
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.
PMID 19435916·Cancer Res·2009
8-other
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
PMID 19470724·Clin Cancer Res·2009
8-other
RPPAML/RIMS: a metadata format and an information management system for reverse phase protein arrays.
PMID 19102773·BMC Bioinformatics·2008
8-other
Is tuberculin testing before BCG vaccination necessary for children over three months of age?
PMID 18540542·Ir Med J·2008
8-other
Individualized molecular medicine: linking functional proteomics to select therapeutics targeting the PI3K pathway for specific patients.
PMID 18546628·Adv Exp Med Biol·2008
6-review
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.
PMID 18676830·Cancer Res·2008
8-other
A novel derivative of the natural agent deguelin for cancer chemoprevention and therapy.
PMID 19139008·Cancer Prev Res (Phila)·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3525 OLENTANGY RIVER RD, STE,4330
COLUMBUS, OH 43214 - Phone
- (614) 255-6900
Quick Facts
- NPI
- 1386936755
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile